Three studies involving 228 centers looking at the effects of the three treatments in people at intermediate risk of, but without, clinical heart disease have recently been conducted.
Three studies involving 228 centers looking at the effects of the three treatments in people at intermediate risk of, but without, clinical heart disease have recently been conducted.